Home/Nanogenics/Nigel Theobald
NT

Nigel Theobald

General Manager

Nanogenics

Therapeutic Areas

Nanogenics Pipeline

DrugIndicationPhase
ECP-105Glaucoma (adjunct to Bleb surgery)Pre-clinical